Annual report
9265.TEDINET S100P29L
Period2021-06-01 → 2022-05-31
Filed2022-08-26
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥55.1bn | 2021-06-01 → 2022-05-31 | Cons. | Net sales |
| Revenue | ¥70.1bn | 2020-06-01 → 2021-05-31 | Cons. | Net sales |
| Revenue | ¥64.7bn | 2019-06-01 → 2020-05-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥61.5bn | 2018-06-01 → 2019-05-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥58.7bn | 2017-06-01 → 2018-05-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥931m | 2021-06-01 → 2022-05-31 | Cons. | Operating income |
| Operating income | ¥969m | 2020-06-01 → 2021-05-31 | Cons. | Operating income |
| Ordinary income | ¥1.0bn | 2021-06-01 → 2022-05-31 | Cons. | Ordinary income |
| Ordinary income | ¥1.0bn | 2020-06-01 → 2021-05-31 | Cons. | Ordinary income |
| Ordinary income | ¥643m | 2019-06-01 → 2020-05-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥617m | 2018-06-01 → 2019-05-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥450m | 2017-06-01 → 2018-05-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥1.0bn | 2021-06-01 → 2022-05-31 | Cons. | Income before income taxes |
| Profit before tax | ¥1.1bn | 2020-06-01 → 2021-05-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥696m | 2021-06-01 → 2022-05-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥678m | 2020-06-01 → 2021-05-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥460m | 2019-06-01 → 2020-05-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥144m | 2018-06-01 → 2019-05-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥221m | 2017-06-01 → 2018-05-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥695m | 2021-06-01 → 2022-05-31 | Cons. | Profit loss |
| Net income | ¥678m | 2020-06-01 → 2021-05-31 | Cons. | Profit loss |
| Total assets | ¥24.1bn | at 2022-05-31 | Cons. | Assets |
| Total assets | ¥24.3bn | at 2021-05-31 | Cons. | Assets |
| Total assets | ¥21.4bn | at 2020-05-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥20.3bn | at 2019-05-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥20.8bn | at 2018-05-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥16.1bn | at 2022-05-31 | Cons. | Liabilities |
| Total liabilities | ¥16.7bn | at 2021-05-31 | Cons. | Liabilities |
| Net assets / equity | ¥8.0bn | at 2022-05-31 | Cons. | Net assets |
| Net assets / equity | ¥7.6bn | at 2021-05-31 | Cons. | Net assets |
| Net assets / equity | ¥6.9bn | at 2020-05-31d | Cons. | Net assets |
| Net assets / equity | ¥6.4bn | at 2019-05-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥6.3bn | at 2018-05-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥4.0bn | at 2022-05-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥3.7bn | at 2021-05-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥4.0bn | at 2022-05-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.7bn | at 2021-05-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.0bn | at 2020-05-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.3bn | at 2019-05-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥2.8bn | at 2018-05-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥581m | 2021-06-01 → 2022-05-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥912m | 2020-06-01 → 2021-05-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥818m | 2019-06-01 → 2020-05-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥101m | 2018-06-01 → 2019-05-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.5bn | 2017-06-01 → 2018-05-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥28m | 2021-06-01 → 2022-05-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥134m | 2020-06-01 → 2021-05-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥34m | 2019-06-01 → 2020-05-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥50m | 2018-06-01 → 2019-05-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥378m | 2017-06-01 → 2018-05-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥230m | 2021-06-01 → 2022-05-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥138m | 2020-06-01 → 2021-05-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥107m | 2019-06-01 → 2020-05-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥366m | 2018-06-01 → 2019-05-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥353m | 2017-06-01 → 2018-05-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥272.67 | 2021-06-01 → 2022-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥265.77 | 2020-06-01 → 2021-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥180.07 | 2019-06-01 → 2020-05-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥56.57 | 2018-06-01 → 2019-05-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥87.04 | 2017-06-01 → 2018-05-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥3,126.18 | at 2022-05-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,969.03 | at 2021-05-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,717.81 | at 2020-05-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,496.1 | at 2019-05-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,457.18 | at 2018-05-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 33.1% | at 2022-05-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 31.2% | at 2021-05-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 32.4% | at 2020-05-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 31.4% | at 2019-05-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 30.1% | at 2018-05-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 8.9% | 2021-06-01 → 2022-05-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 9.3% | 2020-06-01 → 2021-05-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 6.9% | 2019-06-01 → 2020-05-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 2.3% | 2018-06-01 → 2019-05-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 3.6% | 2017-06-01 → 2018-05-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 574 | at 2022-05-31 | Cons. | Number of employees |
| Employees | 553 | at 2021-05-31 | Cons. | Number of employees |
| Employees | 551 | at 2020-05-31d | Cons. | Number of employees |
| Employees | 552 | at 2019-05-31d | Cons. | Number of employees |
| Employees | 556 | at 2018-05-31d | Cons. | Number of employees |
| Revenue | ¥793m | 2021-06-01 → 2022-05-31 | Standalone | Operating revenue1 |
| Revenue | ¥854m | 2020-06-01 → 2021-05-31 | Standalone | Operating revenue1 |
| Revenue | ¥509m | 2019-06-01 → 2020-05-31d | Standalone | Operating revenue1 (5-year summary) |
| Revenue | ¥448m | 2018-06-01 → 2019-05-31d | Standalone | Operating revenue1 (5-year summary) |
| Revenue | ¥280m | 2017-06-01 → 2018-05-31d | Standalone | Operating revenue1 (5-year summary) |
| Operating income | ¥228m | 2021-06-01 → 2022-05-31 | Standalone | Operating income |
| Operating income | ¥346m | 2020-06-01 → 2021-05-31 | Standalone | Operating income |
| Ordinary income | ¥228m | 2021-06-01 → 2022-05-31 | Standalone | Ordinary income |
| Ordinary income | ¥347m | 2020-06-01 → 2021-05-31 | Standalone | Ordinary income |
| Ordinary income | ¥137m | 2019-06-01 → 2020-05-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥128m | 2018-06-01 → 2019-05-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥108m | 2017-06-01 → 2018-05-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥228m | 2021-06-01 → 2022-05-31 | Standalone | Income before income taxes |
| Profit before tax | ¥347m | 2020-06-01 → 2021-05-31 | Standalone | Income before income taxes |
| Net income | ¥228m | 2021-06-01 → 2022-05-31 | Standalone | Profit loss |
| Net income | ¥348m | 2020-06-01 → 2021-05-31 | Standalone | Profit loss |
| Net income | ¥101m | 2019-06-01 → 2020-05-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥125m | 2018-06-01 → 2019-05-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥101m | 2017-06-01 → 2018-05-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥6.5bn | at 2022-05-31 | Standalone | Assets |
| Total assets | ¥6.4bn | at 2021-05-31 | Standalone | Assets |
| Total assets | ¥6.0bn | at 2020-05-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥5.9bn | at 2019-05-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥5.9bn | at 2018-05-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥499m | at 2022-05-31 | Standalone | Liabilities |
| Total liabilities | ¥331m | at 2021-05-31 | Standalone | Liabilities |
| Net assets / equity | ¥6.0bn | at 2022-05-31 | Standalone | Net assets |
| Net assets / equity | ¥6.0bn | at 2021-05-31 | Standalone | Net assets |
| Net assets / equity | ¥5.8bn | at 2020-05-31d | Standalone | Net assets |
| Net assets / equity | ¥5.8bn | at 2019-05-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥5.8bn | at 2018-05-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥229m | at 2022-05-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥401m | at 2021-05-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥89.32 | 2021-06-01 → 2022-05-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥136.46 | 2020-06-01 → 2021-05-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥39.38 | 2019-06-01 → 2020-05-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥48.96 | 2018-06-01 → 2019-05-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥39.5 | 2017-06-01 → 2018-05-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥82 | 2021-06-01 → 2022-05-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥90 | 2020-06-01 → 2021-05-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥54 | 2019-06-01 → 2020-05-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥42 | 2018-06-01 → 2019-05-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥26 | 2017-06-01 → 2018-05-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥2,360.07 | at 2022-05-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,360.75 | at 2021-05-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,278.24 | at 2020-05-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,280.98 | at 2019-05-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,258.01 | at 2018-05-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 92.4% | at 2022-05-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 94.8% | at 2021-05-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 96.9% | at 2020-05-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 99.2% | at 2019-05-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 98.5% | at 2018-05-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 3.8% | 2021-06-01 → 2022-05-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 5.9% | 2020-06-01 → 2021-05-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 1.7% | 2019-06-01 → 2020-05-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 2.2% | 2018-06-01 → 2019-05-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 1.7% | 2017-06-01 → 2018-05-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 2,553,000 | at 2022-05-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 2,553,000 | at 2021-05-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 2,553,000 | at 2020-05-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 2,553,000 | at 2019-05-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 2,553,000 | at 2018-05-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 27 | at 2022-05-31 | Standalone | Number of employees |
| Employees | 24 | at 2021-05-31 | Standalone | Number of employees |
| Employees | 20 | at 2020-05-31d | Standalone | Number of employees |
| Employees | 19 | at 2019-05-31d | Standalone | Number of employees |
| Employees | 20 | at 2018-05-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 48
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | depreciation | 2021-06-01 → 2022-05-31 | ¥36m |
| Reconciling Itemsreconciling | revenue | 2021-06-01 → 2022-05-31 | −¥6m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-06-01 → 2022-05-31 | −¥6m |
| Reconciling Itemsreconciling | segment profit | 2021-06-01 → 2022-05-31 | −¥1.0bn |
| Medical Equipment Manufacturing And Salesreportable segment | depreciation | 2021-06-01 → 2022-05-31 | ¥7m |
| Medical Equipment Manufacturing And Salesreportable segment | employees | at 2022-05-31 | 5 pure |
| Medical Equipment Manufacturing And Salesreportable segment | revenue | 2021-06-01 → 2022-05-31 | ¥288m |
| Medical Equipment Manufacturing And Salesreportable segment | revenue external | 2021-06-01 → 2022-05-31 | ¥287m |
| Medical Equipment Manufacturing And Salesreportable segment | revenue intersegment | 2021-06-01 → 2022-05-31 | ¥385,000 |
| Medical Equipment Manufacturing And Salesreportable segment | segment profit | 2021-06-01 → 2022-05-31 | ¥20m |
| Medical Equipment Salesreportable segment | depreciation | 2021-06-01 → 2022-05-31 | ¥142m |
| Medical Equipment Salesreportable segment | employees | at 2022-05-31 | 527 pure |
| Medical Equipment Salesreportable segment | revenue | 2021-06-01 → 2022-05-31 | ¥54.8bn |
| Medical Equipment Salesreportable segment | revenue external | 2021-06-01 → 2022-05-31 | ¥54.8bn |
| Medical Equipment Salesreportable segment | revenue intersegment | 2021-06-01 → 2022-05-31 | ¥6m |
| Medical Equipment Salesreportable segment | segment profit | 2021-06-01 → 2022-05-31 | ¥2.0bn |
| Medical Mallreportable segment | depreciation | 2021-06-01 → 2022-05-31 | ¥15m |
| Medical Mallreportable segment | revenue | 2021-06-01 → 2022-05-31 | ¥69m |
| Medical Mallreportable segment | revenue external | 2021-06-01 → 2022-05-31 | ¥69m |
| Medical Mallreportable segment | segment profit | 2021-06-01 → 2022-05-31 | −¥47m |
| —segment total | depreciation | 2021-06-01 → 2022-05-31 | ¥164m |
| —segment total | revenue | 2021-06-01 → 2022-05-31 | ¥55.2bn |
| —segment total | revenue external | 2021-06-01 → 2022-05-31 | ¥55.1bn |
| —segment total | revenue intersegment | 2021-06-01 → 2022-05-31 | ¥6m |
| —segment total | segment profit | 2021-06-01 → 2022-05-31 | ¥1.9bn |
| Reconciling Itemsreconciling | depreciation | 2020-06-01 → 2021-05-31 | ¥36m |
| Reconciling Itemsreconciling | revenue | 2020-06-01 → 2021-05-31 | −¥18m |
| Reconciling Itemsreconciling | revenue intersegment | 2020-06-01 → 2021-05-31 | −¥18m |
| Reconciling Itemsreconciling | segment profit | 2020-06-01 → 2021-05-31 | −¥854m |
| Medical Equipment Manufacturing And Salesreportable segment | depreciation | 2020-06-01 → 2021-05-31 | ¥8m |
| Medical Equipment Manufacturing And Salesreportable segment | revenue | 2020-06-01 → 2021-05-31 | ¥360m |
| Medical Equipment Manufacturing And Salesreportable segment | revenue external | 2020-06-01 → 2021-05-31 | ¥359m |
| Medical Equipment Manufacturing And Salesreportable segment | revenue intersegment | 2020-06-01 → 2021-05-31 | ¥348,000 |
| Medical Equipment Manufacturing And Salesreportable segment | segment profit | 2020-06-01 → 2021-05-31 | ¥72m |
| Medical Equipment Salesreportable segment | depreciation | 2020-06-01 → 2021-05-31 | ¥126m |
| Medical Equipment Salesreportable segment | revenue | 2020-06-01 → 2021-05-31 | ¥69.7bn |
| Medical Equipment Salesreportable segment | revenue external | 2020-06-01 → 2021-05-31 | ¥69.7bn |
| Medical Equipment Salesreportable segment | revenue intersegment | 2020-06-01 → 2021-05-31 | ¥17m |
| Medical Equipment Salesreportable segment | segment profit | 2020-06-01 → 2021-05-31 | ¥1.7bn |
| Medical Mallreportable segment | depreciation | 2020-06-01 → 2021-05-31 | ¥14m |
| Medical Mallreportable segment | revenue | 2020-06-01 → 2021-05-31 | ¥67m |
| Medical Mallreportable segment | revenue external | 2020-06-01 → 2021-05-31 | ¥67m |
| Medical Mallreportable segment | segment profit | 2020-06-01 → 2021-05-31 | ¥1m |
| —segment total | depreciation | 2020-06-01 → 2021-05-31 | ¥148m |
| —segment total | revenue | 2020-06-01 → 2021-05-31 | ¥70.1bn |
| —segment total | revenue external | 2020-06-01 → 2021-05-31 | ¥70.1bn |
| —segment total | revenue intersegment | 2020-06-01 → 2021-05-31 | ¥18m |
| —segment total | segment profit | 2020-06-01 → 2021-05-31 | ¥1.8bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,328
| Item | Context | Value | Unit |
|---|---|---|---|
| Total assets (5-year summary) | Prior2YearInstant | 21425232000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant | 24322116000 | JPY |
| Total assets (5-year summary) | CurrentYearInstant | 24086745000 | JPY |
| Net assets per share (5-year summary) | Prior4YearInstant | 2457.18 | |
| Net assets per share (5-year summary) | Prior3YearInstant | 2496.10 | |
| Net assets per share (5-year summary) | Prior2YearInstant | 2717.81 | |
| Net assets per share (5-year summary) | Prior1YearInstant | 2969.03 | |
| Net assets per share (5-year summary) | CurrentYearInstant | 3126.18 | |
| Basic earnings loss per share (5-year summary) | Prior4YearDuration | 87.04 | |
| Basic earnings loss per share (5-year summary) | Prior3YearDuration | 56.57 | |
| Basic earnings loss per share (5-year summary) | Prior2YearDuration | 180.07 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | 265.77 | |
| Basic earnings loss per share (5-year summary) | CurrentYearDuration | 272.67 | |
| Diluted earnings per share (5-year summary) | Prior4YearDuration | － | |
| Diluted earnings per share (5-year summary) | Prior3YearDuration | － | |
| Diluted earnings per share (5-year summary) | Prior2YearDuration | － | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | － | |
| Diluted earnings per share (5-year summary) | CurrentYearDuration | － | |
| Equity to asset ratio (5-year summary) | Prior4YearInstant | 0.301 | |
| Equity to asset ratio (5-year summary) | Prior3YearInstant | 0.314 | |
| Equity to asset ratio (5-year summary) | Prior2YearInstant | 0.324 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.312 | |
| Equity to asset ratio (5-year summary) | CurrentYearInstant | 0.331 | |
| Rate of return on equity (5-year summary) | Prior4YearDuration | 0.036 | |
| Rate of return on equity (5-year summary) | Prior3YearDuration | 0.023 | |
| Rate of return on equity (5-year summary) | Prior2YearDuration | 0.069 | |
| Rate of return on equity (5-year summary) | Prior1YearDuration | 0.093 | |
| Rate of return on equity (5-year summary) | CurrentYearDuration | 0.089 | |
| Price earnings ratio (5-year summary) | Prior4YearDuration | 17.3 | |
| Price earnings ratio (5-year summary) | Prior3YearDuration | 21.3 | |
| Price earnings ratio (5-year summary) | Prior2YearDuration | 10.8 | |
| Price earnings ratio (5-year summary) | Prior1YearDuration | 7.6 | |
| Price earnings ratio (5-year summary) | CurrentYearDuration | 7.1 | |
| Net cash provided by used in operating activities (5-year summary) | Prior4YearDuration | 1493349000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior3YearDuration | -101469000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior2YearDuration | 817815000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior1YearDuration | 911528000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | CurrentYearDuration | 581267000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior4YearDuration | -377883000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior3YearDuration | 49963000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior2YearDuration | -33533000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YearDuration | -134143000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | CurrentYearDuration | -27660000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior4YearDuration | 352714000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior3YearDuration | -366391000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior2YearDuration | -107245000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YearDuration | -137813000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | CurrentYearDuration | -229998000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior4YearInstant | 2753423000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior3YearInstant | 2335526000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |